Human GLIPR1/CRISP7/GLIPR ORF/cDNA clone-Lentivirus particle (NM_006851)

Cat. No.: vGMLP000567

Pre-made Human GLIPR1/CRISP7/GLIPR Lentiviral expression plasmid for GLIPR1 lentivirus packaging, GLIPR1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to GLIPR1/CRISP7 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLP000567 Human GLIPR1 Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLP000567
Gene Name GLIPR1
Accession Number NM_006851
Gene ID 11010
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 801 bp
Gene Alias CRISP7,GLIPR,RTVP1
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGCGTGTCACACTTGCTACAATAGCCTGGATGGTTTCTTTTGTCTCCAATTATTCACACACAGCAAATATTTTGCCAGATATCGAAAATGAAGATTTCATCAAAGACTGCGTTCGAATCCATAACAAGTTCCGATCAGAGGTGAAACCAACAGCCAGTGATATGCTATACATGACTTGGGACCCAGCACTAGCCCAAATTGCAAAAGCATGGGCCAGCAATTGCCAGTTTTCACATAATACACGGCTGAAGCCACCCCACAAGCTGCACCCAAACTTCACTTCACTGGGAGAGAACATCTGGACTGGGTCTGTGCCCATTTTTTCTGTGTCTTCCGCCATCACAAACTGGTATGACGAAATCCAGGACTATGACTTCAAGACTCGGATATGCAAAAAAGTCTGTGGCCACTACACTCAGGTTGTTTGGGCAGATAGTTACAAAGTTGGCTGCGCAGTTCAATTTTGCCCTAAAGTTTCTGGCTTTGACGCTCTTTCCAATGGAGCACATTTTATATGCAACTACGGACCAGGAGGGAATTACCCAACTTGGCCATATAAGAGAGGAGCCACCTGCAGTGCCTGCCCCAATAATGACAAGTGTTTGGACAATCTCTGTGTTAACCGACAGCGAGACCAAGTCAAACGTTACTACTCTGTTGTATATCCAGGCTGGCCCATATATCCACGTAACAGATACACTTCTCTCTTTCTCATTGTTAATTCAGTAATTCTAATACTGTCTGTTATAATTACCATTTTGGTACAGCACAAGTACCCTAATTTAGTTCTTTTGGACTAA
ORF Protein Sequence MRVTLATIAWMVSFVSNYSHTANILPDIENEDFIKDCVRIHNKFRSEVKPTASDMLYMTWDPALAQIAKAWASNCQFSHNTRLKPPHKLHPNFTSLGENIWTGSVPIFSVSSAITNWYDEIQDYDFKTRICKKVCGHYTQVVWADSYKVGCAVQFCPKVSGFDALSNGAHFICNYGPGGNYPTWPYKRGATCSACPNNDKCLDNLCVNRQRDQVKRYYSVVYPGWPIYPRNRYTSLFLIVNSVILILSVIITILVQHKYPNLVLLD

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T70201-Ab Anti-GLIP1/ GLIPR1/ CRISP7 monoclonal antibody
    Target Antigen GM-Tg-g-T70201-Ag GLIPR1 VLP (virus-like particle)
    ORF Viral Vector pGMLP000567 Human GLIPR1 Lentivirus plasmid
    ORF Viral Vector vGMLP000567 Human GLIPR1 Lentivirus particle


    Target information

    Target ID GM-T70201
    Target Name GLIPR1
    Gene Group Identifier
    (Target Gene ID in Homo species)
    11010
    Gene ID 100058283 (Equus caballus), 101087587 (Felis catus), 11010 (Homo sapiens), 299783 (Rattus norvegicus)
    474452 (Canis lupus familiaris), 718956 (Macaca mulatta), 73690 (Mus musculus), 767905 (Bos taurus)
    Gene Symbols & Synonyms GLIPR1,Glipr1,GLIPR,RTVP1,CRISP7,RTVP-1,gliPR 1,mRTVP-1,2410114O14Rik
    Target Alternative Names 2410114O14Rik,CRISP7,GLIPR,GLIPR1,GliPR 1,Glioma pathogenesis-related protein 1,Glipr1,Protein RTVP-1,RTVP-1,RTVP1,gliPR 1,mRTVP-1
    Uniprot Accession P48060,Q9CWG1
    Additional SwissProt Accessions: P48060,Q9CWG1
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category Therapeutics Target
    Disease cancer
    Disease from KEGG
    Gene Ensembl ENSECAG00000015687, ENSG00000139278, ENSCAFG00845025911, ENSMUSG00000056888, ENSBTAG00000011590
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.